Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Progeny Systems is a high-tech engineering and manufacturing firm that provides advanced technology solutions across defense, healthcare, and bioinformatics sectors. The company's medical division specializes in healthcare informatics and diagnostic tools, offering products such as Vendor Neutral Archives (VNA), Computer-Aided Detection (CAD) for oncology, and telemedicine systems. Progeny's bioinformatics work includes the development of automated tools for proteomic data analysis and the detection of biological agents. Acquired by Lockheed Martin in 2022, the company continues to leverage its expertise in signal processing and systems integration to enhance diagnostic accuracy and data interoperability in clinical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Progeny Systems.